Ocean Bio-Chem, Inc.

The company's financials show resilient growth, with revenue advancing from $21.48M in Q3 2021 to $15.21M in Q2 2022. Gross profit remained healthy with margins at 35% in Q2 2022 compared to 35% in Q3 2021. Operating income hit -$329388.00 last quarter, sustaining a consistent -2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $131686.00. Net income dropped to -$321395.00, while earnings per share reached -$0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.